Bio Rad实验室(BIO)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BIO Bio Rad实验室

总统日休市 02-14 16:00:00 EST

277.16

-29.20

-9.53%

盘后277.16

+0.000.00%

19:59 EST

最高301.98	最低273.67	成交量106.55万
今开301.98	昨收306.36	日振幅9.24%
总市值77.60亿	流通市值53.85亿	总股本2,800万
成交额3.01亿	换手率5.48%	流通股本1,943万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BIO","market":"US","secType":"STK","nameCN":"Bio Rad实验室","latestPrice":277.16,"timestamp":1739566800000,"preClose":306.36,"halted":0,"volume":1065495,"hourTrading":{"tag":"盘后","latestPrice":277.16,"preClose":277.16,"latestTime":"19:59 EST","volume":1004,"amount":278026.55,"timestamp":1739581145452},"delay":0,"floatShares":19428125,"shares":27996765,"eps":-27.407322,"marketStatus":"总统日休市","change":-29.2,"latestTime":"02-14 16:00:00 EST","open":301.98,"high":301.98,"low":273.6725,"amount":300905270.9055,"amplitude":0.092399,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-27.407322,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1739869200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":306.36,"preHourTrading":{"tag":"盘前","latestPrice":290,"preClose":306.36,"latestTime":"09:09 EST","volume":675,"amount":205520.6925,"timestamp":1739542190515},"postHourTrading":{"tag":"盘后","latestPrice":277.16,"preClose":277.16,"latestTime":"19:59 EST","volume":1004,"amount":278026.55,"timestamp":1739581145452},"volumeRatio":4.269975732698857,"impliedVol":0.4318,"impliedVolPercentile":0.6773},"requestUrl":"/m/hq/s/BIO/wiki","defaultTab":"wiki","newsList":[{"id":"2511616645","title":"BUZZ--美国股票走势-Meta Platforms、Dexcom、戴尔","url":"https://stock-news.laohu8.com/highlight/detail?id=2511616645","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511616645?lang=zh_cn&edition=full","pubTime":"2025-02-15 02:53","pubTimestamp":1739559209,"startTime":"0","endTime":"0","summary":".N美国东部时间13:30，道琼斯工业平均指数.DJI下跌0.21%，报44,616.89点。标普500指数.SPX上涨0.04%，报6,117.42点；纳斯达克综合指数.IXIC上涨0.21%，报19,988.15点。标准普尔 500 指数.PG.INX百分比涨幅前三名是： ** Airbnb Inc ABNB.OQ，上涨 14.7. ** West Pharmaceutical Services Inc WST.N，上涨 10.8 标普500指数.PL.INX跌幅前三名： ** GoDaddy Inc GDDY.N，下跌 14.2. ** Bolt Projects Holdings Inc BSLK.OQ, 下跌48.4%。BUZZ - 第四季度财报发布后下跌；伯克希尔哈撒韦公司减持股份  nL4N3P50V7  ** Applied Materials Inc AMAT.O：。BUZZ--第二季度收入预期黯淡后下跌 nL4N3P50UH  ** JD.com Inc JD.O：。BUZZ - 瑞穗上调评级后上涨 nL4N3P5126  ** Analog Devices Inc ADI.O：","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250214:nL4S3P51GU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310799852.SGD","DVA","HCC","NEM","NVD2.UK","ADI","NVIW.SI","WYNN","SNVD.UK","TWLO","NPCE","AU","FND","NNOX","2NVD.UK","BIO","CELZ","ALB","META","NVDU","NVDD","THS","ROKU","3NVD.UK","NVDX","DXCM","NVD3.UK","PACB","CARR","WAT","NVDY","LU0561508036.HKD","GFI","LU1720051017.SGD","NVD","SG9999014559.SGD","AMAT","NVDS","IFF","NVDS.UK","JTAI"],"gpt_icon":1},{"id":"2511969697","title":"Bio Rad实验室跌3.74% 股价跌破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2511969697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511969697?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:32","pubTimestamp":1739543524,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时32分，Bio Rad实验室股票出现波动，股价急速跳水3.74%。截至发稿，该股报294.90美元/股，成交量4797股，换手率0.02%，振幅2.31%。Bio Rad实验室股票所在的医疗器械行业中，整体涨幅为0.29%。Bio Rad实验室公司简介：伯乐生命医学产品有限公司总部位于美国加利福尼亚州的Hercules，为临床诊断和生命科学市场开发、制造和销售产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502142232059885897d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502142232059885897d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIO","BK4585","BK4121","LU1169589451.USD","BIO.B","LU1169590202.USD","BK4588"],"gpt_icon":0},{"id":"2511505271","title":"Bio-Rad Laboratories(BIO.US)：2024年Q4财报实现营收6.675亿美元，前值为6.812亿美元，预期值为6.798亿美元；每股收益为2.90美元，前值为3.10美元，预期值为2.88美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511505271","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511505271?lang=zh_cn&edition=full","pubTime":"2025-02-14 06:22","pubTimestamp":1739485343,"startTime":"0","endTime":"0","summary":"Bio-Rad Laboratories(BIO.US)：2024年Q4财报实现营收6.675亿美元，前值为6.812亿美元，预期值为6.798亿美元；每股收益为2.90美元，前值为3.10美元，预期值为2.88美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14062248151181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BIO","BIO.B"],"gpt_icon":0},{"id":"2511503652","title":"Bio Rad Laboratories Inc 报告截至 12 月 31 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2511503652","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511503652?lang=zh_cn&edition=full","pubTime":"2025-02-14 06:02","pubTimestamp":1739484140,"startTime":"0","endTime":"0","summary":"Bio Rad Laboratories Inc 报告截至 12 月 31 日的季度业绩 - 收益摘要Bio Rad Laboratories Inc BIO.N公布的截至12月31日的季度调整后每股收益为2.90美元，低于去年同期的每股收益3.10美元。Bio Rad Laboratories Inc 公布的本季度每股收益为亏损 25.57 美元。该公司一季度亏损 7.158 亿美元。本季度，Bio Rad Laboratories Inc 的股价下跌了 4.9%。华尔街对 Bio Rad Laboratories Inc 的 12 个月目标价中位数为 395.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nL4T3P4249:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIO","BK4121","LU1169589451.USD","BK4588","LU1169590202.USD","BK4585"],"gpt_icon":0},{"id":"1116382379","title":"Bio-Rad Laboratories 2024年第四季度每股收益 $2.90 超过预期 $2.86，销售额 $6.675亿 未达预期 $6.793亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1116382379","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116382379?lang=zh_cn&edition=full","pubTime":"2025-02-14 05:22","pubTimestamp":1739481743,"startTime":"0","endTime":"0","summary":"Bio-Rad Laboratories报告季度每股收益为 $2.90，高于分析师一致预期的 $2.86，增幅为 1.4%。与去年同期的每股收益 $3.10 相比，下降了 6.45%。公司报告季度销售额为 $6.675亿，低于分析师一致预期的 $6.793亿，减少了 1.74%。以上内容来自Benzinga Earnings专栏，原文如下：Bio-Rad Laboratories  reported quarterly earnings of $2.90 per share which beat the analyst consensus estimate of $2.86 by 1.4 percent. This is a 6.45 percent decrease over earnings of $3.10 per share from the same period last year.  The company reported quarterly sales of $667.50 million which missed the analyst consensus esti","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Bio-Rad Laboratories 2024年第四季度每股收益 $2.90 超过预期 $2.86，销售额 $6.675亿 未达预期 $6.793亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIO","BIO.B"],"gpt_icon":0},{"id":"2510303411","title":"Bio Rad实验室盘中异动 股价大跌7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510303411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510303411?lang=zh_cn&edition=full","pubTime":"2025-02-12 22:54","pubTimestamp":1739372040,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日22时54分，Bio Rad实验室股票出现异动，股价大幅下挫7.12%。截至发稿，该股报319.37美元/股，成交量250股，换手率0.00%，振幅0.00%。Bio Rad实验室股票所在的医疗器械行业中，整体跌幅为1.01%。Bio Rad实验室公司简介：伯乐生命医学产品有限公司总部位于美国加利福尼亚州的Hercules，为临床诊断和生命科学市场开发、制造和销售产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212225400abcc627c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212225400abcc627c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1169589451.USD","LU1169590202.USD","BK4585","BK4121","BK4588","BIO","BIO.B"],"gpt_icon":0},{"id":"2510603638","title":"Bio Rad实验室盘中异动 股价大跌5.00%报325.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510603638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510603638?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:03","pubTimestamp":1739206996,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日01时03分，Bio Rad实验室股票出现异动，股价快速下挫5.00%。截至发稿，该股报325.01美元/股，成交量8.7759万股，换手率0.31%，振幅4.81%。Bio Rad实验室股票所在的医疗器械行业中，整体涨幅为0.29%。Bio Rad实验室公司简介：伯乐生命医学产品有限公司总部位于美国加利福尼亚州的Hercules，为临床诊断和生命科学市场开发、制造和销售产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211010317988095cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211010317988095cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1169589451.USD","LU1169590202.USD","BK4585","BK4121","BK4588","BIO","BIO.B"],"gpt_icon":0},{"id":"2502863377","title":"和铂医药-B(02142)及科伦博泰(06990)与WINDWARD BIO AG就HBM9378/SKB378订立独家授权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2502863377","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502863377?lang=zh_cn&edition=full","pubTime":"2025-01-10 21:04","pubTimestamp":1736514297,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B 公布，公司及科伦博泰已与 Windward Bio AG就授权方联合开发的抗胸腺基质淋巴细胞生成素单克隆抗体HBM9378/SKB378订立独家授权协议。4500万美元的预付款及近期里程碑付款包括现金付款及Windward Bio母公司的股权。基于上述，授权协议的订立将授权方与Windward Bio 的研发、生产及商业化能力整合在一起，为HBM9378/SKB378走向商业化提供支持并确立有利市场地位。授权协议的实施亦让公司能够将HBM9378/SKB378推向全球市场，令其商业价值得到最大化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1236337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0196878994.USD","AG","06990","BK1574","LU1169589451.USD","BK4210","BIO","BK4585","BK1583","BK1161","02142","BK4121","BK4588","LU1169590202.USD"],"gpt_icon":0},{"id":"2501470122","title":"9.5个亿！伯乐收购PCR公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2501470122","media":"IVD资讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501470122?lang=zh_cn&edition=full","pubTime":"2025-01-06 14:03","pubTimestamp":1736143401,"startTime":"0","endTime":"0","summary":"来源：CACLP波兰生命科学公司 Scope Fluidics近日表示，在收到交易的最后一笔款项后，该公司最近敲定了以 1.3 亿美元的价格将其子公司 Curiosity Diagnostics 出售给 Bio-Rad Laboratories 的交易。两年前，Bio-Rad 宣布两家公司已达成 1.7 亿美元的协议，收购 Curiosity Diagnostics，该公司一直在开发一种名为 PCR One 的 PCR 系统。该 sample-to-answer PCR 检测系统用于检测多达 20 个靶标，周转时间为 15 分钟。根据协议，2024 年 11 月初，Bio-Rad Laboratories 向 Scope Fluidics 转账 3000 万美元，作为与收购特殊目的实体 Curiosity Diagnostics 相关的最终和解金。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106140754aba00a7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106140754aba00a7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BIO","BIO.B"],"gpt_icon":0},{"id":"2490705031","title":"Bio Rad实验室盘中异动 股价大涨5.19%报342.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490705031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490705031?lang=zh_cn&edition=full","pubTime":"2024-12-10 01:54","pubTimestamp":1733766876,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日01时54分，Bio Rad实验室股票出现异动，股价大幅拉升5.19%。截至发稿，该股报342.38美元/股，成交量7.0331万股，换手率0.25%，振幅4.72%。Bio Rad实验室股票所在的医疗器械行业中，整体跌幅为0.45%。Bio Rad实验室公司简介：伯乐生命医学产品有限公司总部位于美国加利福尼亚州的Hercules，为临床诊断和生命科学市场开发、制造和销售产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210015436984acd3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210015436984acd3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIO","BIO.B","BK4585","LU1169589451.USD","LU1169590202.USD","BK4588","BK4121"],"gpt_icon":0},{"id":"2489497769","title":"Bio Rad实验室盘中异动 下午盘大幅跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489497769","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489497769?lang=zh_cn&edition=full","pubTime":"2024-12-06 04:07","pubTimestamp":1733429227,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日04时07分，Bio Rad实验室股票出现异动，股价快速跳水5.03%。截至发稿，该股报321.42美元/股，成交量8.2659万股，换手率0.30%，振幅3.47%。Bio Rad实验室股票所在的医疗器械行业中，整体跌幅为1.31%。Bio Rad实验室公司简介：伯乐生命医学产品有限公司总部位于美国加利福尼亚州的Hercules，为临床诊断和生命科学市场开发、制造和销售产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206040707ab609382&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206040707ab609382&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1169590202.USD","BK4585","BK4588","BK4121","BIO.B","BIO","LU1169589451.USD"],"gpt_icon":0},{"id":"2487355060","title":"PASSAGE BIO股价上涨 25%，此前韦德布什对其发布了“跑赢大盘”的覆盖评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2487355060","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487355060?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:40","pubTimestamp":1732891211,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BIO","LU1169590202.USD","BK4585","LU1169589451.USD","PASG","BK4139","BK4588","BK4121"],"gpt_icon":0},{"id":"2483305637","title":"Bio Rad实验室盘中异动 早盘急速跳水5.02%报332.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483305637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483305637?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:27","pubTimestamp":1731684445,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时27分，Bio Rad实验室股票出现波动，股价快速下挫5.02%。截至发稿，该股报332.65美元/股，成交量3.5059万股，换手率0.13%，振幅4.12%。Bio Rad实验室股票所在的医疗器械行业中，整体涨幅为0.57%。Bio Rad实验室公司简介：伯乐生命医学产品有限公司总部位于美国加利福尼亚州的Hercules，为临床诊断和生命科学市场开发、制造和销售产品和解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115232725971a6e37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115232725971a6e37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BIO","LU1169590202.USD","LU1169589451.USD","BK4588","BIO.B","BK4121"],"gpt_icon":0},{"id":"2483379717","title":"BIO-Key International Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483379717","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483379717?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:02","pubTimestamp":1731679364,"startTime":"0","endTime":"0","summary":"   * BIO-Key International Inc   报告，截至9月30日的季度调整后每股亏损39美分，高于去年同期的每股收益1.44美元。* 收入同比增长 17.3%，达到 214 万美元；分析师预期为 160 万美元。* BIO-Key International Inc 的股价本季度上涨了 6.3%，今年迄今为止下跌了 66.0%。华尔街对 BIO-Key International Inc 的 12 个月目标价中位数为 3.00  本摘要由 LSEG 11 月 15 日 02:02 p.m. UTC 数据自动生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4097","BK4121","LU1169589451.USD","BIO","BKYI","LU1169590202.USD"],"gpt_icon":0},{"id":"2483098693","title":"BIO-Key International Inc    预计每股亏损 58 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2483098693","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483098693?lang=zh_cn&edition=full","pubTime":"2024-11-13 08:02","pubTimestamp":1731456170,"startTime":"0","endTime":"0","summary":"   * BIO-Key International Inc    预计将在11月14日公布截至2024年9月30日的季度收入报告。* LSEG 的分析师平均预计 BIO-Key International Inc 每股亏损 58 美分。* 一位分析师对该公司股票的评级为 \"买入\"。* 华尔街对 BIO-Key International Inc 的 12 个月目标价中位数为 3.00 美元，高于其上一次收盘价 1.05 美元。11月13日 - 本摘要于北京时间 11 月 13 日 00:02 时生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIO","BKYI"],"gpt_icon":0},{"id":"2482496013","title":"DeSci + 生物科技，BIO Protocol 将加密货币带入新应用场景","url":"https://stock-news.laohu8.com/highlight/detail?id=2482496013","media":"TechFlow深潮","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482496013?lang=zh_cn&edition=full","pubTime":"2024-11-09 11:09","pubTimestamp":1731121757,"startTime":"0","endTime":"0","summary":"BIO协会（BIO Association）今天正式宣布了其社区启动和公平发射，BIO 协会是由 VitaDAO 主要成员创立的一家瑞士非营利组织，VitaDAO是辉瑞风投部门和 Balaji Srinivasan 支持的 DeSci 去中心化科学组织。BIO 协会旨在开发一个去中心化的生物技术网络，并作为链上科学社区的启动平台，连接生物技术和加密货币领域。目前，B...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/Or024jMBJhDTmrQSTCNr7316_3bq3WVeLh-omm-zzWt7kAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/Or024jMBJhDTmrQSTCNr7316_3bq3WVeLh-omm-zzWt7kAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241109A032NR00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241109A032NR00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["FBTC","BIO","EZBC","BK4121","BTCW","GBTC","HODL","LU1169589451.USD","BRRR","DEFI","BITO","BK4594","BK4588","BTCO","LU1169590202.USD","BK4585"],"gpt_icon":1},{"id":"2482058485","title":"KALA BIO Inc   预计每股亏损 2.43 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482058485","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482058485?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:04","pubTimestamp":1731081860,"startTime":"0","endTime":"0","summary":"   * KALA BIO Inc    预计在11月11日公布截至2024年9月30日的财报时，季度营收将没有变化(预计)。*    * LSEG的分析师平均预计KALA BIO公司每股亏损2.43美元。* 目前分析师对该公司股票的平均评级为 \"强力买入\"，建议的细目为2个 \"强力买入 \"或 \"买入\"，没有 \"持有\"，也没有 \"卖出 \"或 \"强力卖出\"。* 华尔街对 KALA BIO Inc 的 12 个月目标价中位数为 15.00 美元，高于其最新收盘价 6.87 美元。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIO","KALA"],"gpt_icon":0},{"id":"2480606903","title":"Bio Rad实验室2024财年第三财季实现净利润6.53亿美元，同比增加516.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480606903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480606903?lang=zh_cn&edition=full","pubTime":"2024-11-04 00:01","pubTimestamp":1730649679,"startTime":"0","endTime":"0","summary":"11月4日，Bio Rad实验室公布财报，公告显示公司2024财年第三财季净利润为6.53亿美元，同比增加516.04%；其中营业收入为6.50亿美元，同比增加2.85%，每股基本收益为23.37美元。从资产负债表来看，Bio Rad实验室总负债31.16亿美元，其中短期债务44.10百万美元，资产负债比为3.41，流动比率为6.14。机构评级：截至2024年11月4日，当前有6家机构对Bio Rad实验室目标价做出预测，其中目标均价为397.33美元，其中最低目标价为315.00美元，最高目标价为469.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104000231a211d3d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104000231a211d3d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIO","BIO.B"],"gpt_icon":0},{"id":"2479942039","title":"美国研究综述-Altair 工程公司、布林克国际公司、梅塔公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2479942039","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479942039?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:41","pubTimestamp":1730385704,"startTime":"0","endTime":"0","summary":"    路透10月31日 - 华尔街证券分析师周四调整了对Altair Engineering、Brinker International和Meta等几家美国上市公司的评级和目标价。要闻 * Altair Engineering Inc   ：尼德姆将其评级从 \"买入 \"下调至 \"持有 * Blackbaud Inc   ：贝雅将其评级从 \"跑赢大盘 \"下调至 \"中性\"。* Brinker International Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Meta   ：贝尔德将目标价从605美元上调至630美元 以下是路透周四报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BMPRXN33.USD","IE00BZ199S13.USD","BK4141","LU2264538146.SGD","ATI","EAT","ABBV","ATNI","BKNG","BMRC","ALL","ALKT","ARCC","ANSS","AXTA","CWH","BL","ATEC","AUR","ALHC","LU1169589451.USD","BIIB","ALRS","BK4140","BPMC","CDW","IE0009354923.USD","IE00BMPRXR70.SGD","TECH","ADP","IE00BFXG0V08.USD","BLKB","LU0061474960.USD","CAT","CHRW","BRO","ALTR","ALMS","AVT","BIO","AEIS","ARVN","AVDL","BG","LU1854104046.USD","META","AX"],"gpt_icon":1},{"id":"1197166163","title":"异动解读 | Bio Rad实验室股价大涨7.73% 分析师看好长期前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1197166163","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197166163?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:03","pubTimestamp":1730383419,"startTime":"0","endTime":"0","summary":"10月31日,Bio Rad实验室股价盘中大涨7.73%,报收于349.76美元/股,引发市场广泛关注。据报道,公司最新一季度营收和净利润数据表现亮眼,且机构分析师对其长期增长前景持乐观看法。消息面上,Bio Rad上一季度实现营业收入6.38亿美元,环比增长5.2%,超出预期。多家机构调高了对Bio Rad的评级和目标价。分析人士认为,Bio Rad具备全面的产品线和创新管线,有望持续受益于生命科学和医疗健康市场的快速增长。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BIO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bio-rad.com","stockEarnings":[{"period":"1week","weight":-0.1899},{"period":"1month","weight":-0.1891},{"period":"3month","weight":-0.1347},{"period":"6month","weight":-0.1487},{"period":"1year","weight":-0.1569},{"period":"ytd","weight":-0.1563}],"compareEarnings":[{"period":"1week","weight":0.0149},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.0409},{"period":"6month","weight":0.0999},{"period":"1year","weight":0.2145},{"period":"ytd","weight":0.0403}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bio-Rad Laboratories, Inc.成立于1952年并于1957年成立为公司。它早期致力于研究和生产用于生物化学，制药和其他生命科学研究运用的专用化学品。在其首次技术分离套件和生命科学研究材料都有所发展的情况下，它进入了临床诊断学领域。通过内部的研发努力和决策，它向不同的市场进行了扩张。现在，Bio-Rad为生命科学研究，医疗保健，分析化学和其他市场生产提供了一系列的产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.02772},{"month":2,"riseRate":0.577778,"avgChangeRate":0.004642},{"month":3,"riseRate":0.636364,"avgChangeRate":0.041103},{"month":4,"riseRate":0.622222,"avgChangeRate":0.043048},{"month":5,"riseRate":0.6,"avgChangeRate":0.017548},{"month":6,"riseRate":0.511111,"avgChangeRate":0.002824},{"month":7,"riseRate":0.577778,"avgChangeRate":0.008353},{"month":8,"riseRate":0.4,"avgChangeRate":-0.00089},{"month":9,"riseRate":0.422222,"avgChangeRate":-0.012005},{"month":10,"riseRate":0.466667,"avgChangeRate":-0.005097},{"month":11,"riseRate":0.622222,"avgChangeRate":0.026396},{"month":12,"riseRate":0.644444,"avgChangeRate":0.023105}],"exchange":"NYSE","name":"Bio Rad实验室","nameEN":"Bio-Rad Laboratories"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bio Rad实验室(BIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Bio Rad实验室(BIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Bio Rad实验室,BIO,Bio Rad实验室股票,Bio Rad实验室股票老虎,Bio Rad实验室股票老虎国际,Bio Rad实验室行情,Bio Rad实验室股票行情,Bio Rad实验室股价,Bio Rad实验室股市,Bio Rad实验室股票价格,Bio Rad实验室股票交易,Bio Rad实验室股票购买,Bio Rad实验室股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bio Rad实验室(BIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Bio Rad实验室(BIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况